Glucose and glucosamine transporters (GLUT/SGLT)

Cellular glucose and glucosamine uptake is primarily mediated by two families of membrane proteins: the facilitative glucose transporters (GLUTs), encoded by the SLC2A gene family, and the sodium-glucose linked transporters (SGLTs), encoded by the SLC5A gene family (Allied Academies, 2025; Wikipedia). These transporters are essential for maintaining energy homeostasis, as glucose is the primary fuel for most mammalian cells, while glucosamine serves as a key substrate for the hexosamine biosynthetic pathway (HBP) (MDPI, 2021). GLUT1, GLUT2, and GLUT4 are the principal isoforms involved in the uptake of both hexoses, with GLUT2 notably possessing a high affinity for glucosamine (NIH, 1.2.3). In pathological states such as diabetes, SGLT2 transporters in the renal tubules are targeted by inhibitors like canagliflozin to promote glucose excretion and lower blood sugar (NIH, 1.4.2). In oncology, many tumors overexpress GLUT1 to sustain high glycolytic rates, a phenomenon known as the Warburg effect, making these transporters targets for experimental inhibitors like BAY-876 (NIH, 1.3.3; MDPI, 2020). Furthermore, exogenous glucosamine is utilized as a therapeutic agent in osteoarthritis, where it is transported into chondrocytes to support the synthesis of glycosaminoglycans and the repair of the extracellular matrix (NIH, 1.1.1). Drugs like insulin regulate these pathways by stimulating the translocation of GLUT4 to the plasma membrane, thereby increasing glucose uptake in muscle and adipose tissue (Wikipedia). Safety concerns associated with modulating these pathways include hypoglycemia and, in the case of SGLT2 inhibitors, an increased risk of diabetic ketoacidosis and genital infections (NIH, 1.4.2).

Other names

Facilitative glucose transportersSodium-glucose linked transportersSLC2 familySLC5 familyHexose transport systemGlucose uptake pathway

Facilitated diffusion and secondary active transport of hexoses; competitive inhibition of glucose uptake by glucosamine; insulin-stimulated translocation of transporters to the cell membrane.